The IL18 Knockout CAL-27 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout population derived from the CAL-27 human oral squamous cell carcinoma cell line, with targeted disruption of the IL18 gene encoding interleukin-18 (IL-18). This loss-of-function model provides a versatile tool for investigating the roles of IL-18 in cancer biology, inflammatory signaling, and immune modulation without relying on single-cell clonal expansion. The polyclonal format reflects a heterogeneous pool of edited cells, preserving genetic diversity and mitigating clonal artifacts while enabling robust analysis of IL18-dependent phenotypes in an oral cancer context.
The parental CAL-27 cell line originates from a human tongue squamous cell carcinoma and is extensively employed as a model system for oral cancer research. CAL-27 cells exhibit key characteristics of squamous cell carcinomas, including aggressive growth and invasive potential, making them a relevant substrate for dissecting molecular mechanisms driving oral carcinogenesis, tumor progression, and therapeutic resistance. This adherent epithelial line retains genomic features and signaling dependencies typical of head and neck malignancies, offering a clinically pertinent background for gene perturbation studies.
IL-18 is a proinflammatory cytokine belonging to the IL-1 superfamily, primarily processed and secreted following inflammasome activation by caspase-1. Upon binding to its heterodimeric receptor complex comprising IL18R1 and IL18RAP, IL-18 initiates intracellular signaling cascades that converge on NF-??B and MAPK pathways via the adaptor molecule MYD88 and kinases IRAK4 and TRAF6. Downstream, these cascades drive the expression of interferon-gamma (IFNG), tumor necrosis factor (TNF), CXCL8 (IL-8), interleukin-6 (IL6), and matrix metalloproteinases (MMPs), while also potentiating Th1 immune responses. Thus, IL-18 sits at the nexus of innate and adaptive immunity, linking inflammasome activation to transcriptional programs mediated by NFKB1, RELA, and MAPK1.
In CAL-27 cells, IL18 knockout abolishes IL-18-mediated signaling, leading to attenuated NF-??B and MAPK activation and diminished production of proinflammatory cytokines and MMPs. This genetic disruption likely reshapes the tumor inflammatory microenvironment and disrupts communication with immune cells, providing a defined system to dissect roles of IL-18 in cancer cell autonomous functions??including proliferation, migration, and invasion??and in immune evasion. Additionally, given IL-18’s involvement in chronic inflammatory and autoimmune disorders, these cells serve as a relevant epithelial model for broader inflammatory pathway analysis.
This knockout model supports diverse applications: quantifying IL-18 via western blotting, ELISA, or RT-qPCR; NF-??B reporter assays; cytokine profiling; cell proliferation, migration, and invasion assays; and co-culture with immune cells to probe tumor-immune interactions. The polyclonal format is suited for high-throughput pathway modulator screening and genetic rescue experiments. Comparative studies with wild-type CAL-27 cells enable precise dissection of IL18-dependent functions in oral cancer and inflammation. For inquiries, please contact Ascent Research.
